We implanted the murine mouse prostate tumor cell line RM9 and melanoma cell line B16F10 that were engineered to express human sMICB (designated as RM9-sMICB and B16-sMICB respectively) subcutaneously into cohorts of syngeneic MICB transgenic mice. The gene discussed is MICB; the disease is prostate neoplasm.